Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Assessment of hepatic portal perfusion using T2 measurements of Gd-DTPA.

Uematsu H, Yamada H, Sadato N, Muramoto S, Inoue H, Hayashi K, Yonekura Y, Kimura H, Sakuma H, Matsuda T, Hayashi N, Yamamoto K, Ishii Y.

J Magn Reson Imaging. 1998 May-Jun;8(3):650-4.

PMID:
9626881
2.

Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.

Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.

AJR Am J Roentgenol. 1999 Jun;172(6):1547-54.

PMID:
10350287
3.
4.

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.

AJR Am J Roentgenol. 2009 Oct;193(4):1053-60. doi: 10.2214/AJR.08.1946.

PMID:
19770329
5.

Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Kogita S, Imai Y, Okada M, Kim T, Onishi H, Takamura M, Fukuda K, Igura T, Sawai Y, Morimoto O, Hori M, Nagano H, Wakasa K, Hayashi N, Murakami T.

Eur Radiol. 2010 Oct;20(10):2405-13. doi: 10.1007/s00330-010-1812-9. Epub 2010 May 19.

PMID:
20490505
6.
7.

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.

Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.

Liver Transpl. 2012 Jul;18(7):850-7. doi: 10.1002/lt.23426.

8.
9.

Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.

Chandarana H, Block TK, Ream J, Mikheev A, Sigal SH, Otazo R, Rusinek H.

Invest Radiol. 2015 Feb;50(2):88-94. doi: 10.1097/RLI.0000000000000105.

10.

Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.

Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M.

World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.

11.

Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.

Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.

J Magn Reson Imaging. 2009 Mar;29(3):636-40. doi: 10.1002/jmri.21689.

PMID:
19243060
12.

Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.

Chiu FY, Jao JC, Chen CY, Liu GC, Jaw TS, Chiou YY, Hsu FO, Hsu JS.

J Comput Assist Tomogr. 2005 Mar-Apr;29(2):176-80.

PMID:
15772533
13.

Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging.

Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):258-63. doi: 10.1016/j.ijrobp.2012.02.037. Epub 2012 Apr 18.

14.

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.

Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.

Radiology. 1996 Jul;200(1):59-67.

PMID:
8657946
15.

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.

Keller S, Sedlacik J, Schuler T, Buchert R, Avanesov M, Zenouzi R, Lohse AW, Kooijman H, Fiehler J, Schramm C, Yamamura J.

Eur Radiol. 2019 Feb;29(2):818-828. doi: 10.1007/s00330-018-5614-9. Epub 2018 Jul 16.

PMID:
30014204
16.

How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver?

Aschoff AJ, Merkle EM, Wong V, Zhang Q, Mendez MM, Duerk JL, Lewin JS.

J Magn Reson Imaging. 2001 Jan;13(1):57-63.

PMID:
11169804
17.

The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.

Wang YC, Chou CT, Lin CP, Chen YL, Chen YF, Chen RC.

PLoS One. 2017 Mar 29;12(3):e0174594. doi: 10.1371/journal.pone.0174594. eCollection 2017.

18.

Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.

Talakic E, Steiner J, Kalmar P, Lutfi A, Quehenberger F, Reiter U, Fuchsjäger M, Schöllnast H.

Eur J Radiol. 2014 Apr;83(4):607-11. doi: 10.1016/j.ejrad.2013.12.010. Epub 2013 Dec 16.

PMID:
24380639
19.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.

Ippolito D, Trattenero C, Talei Franzesi C, Casiraghi A, Lombardi S, Vacirca F, Corso R, Sironi S.

J Comput Assist Tomogr. 2016 Sep-Oct;40(5):692-700. doi: 10.1097/RCT.0000000000000427.

PMID:
27560010
20.

Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.

Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.

Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045.

PMID:
18608015

Supplemental Content

Support Center